Gewalife Tech India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 6 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth 3134.17%
- Profit Growth 127.21%
- Ebitda 91.03%
- Net Worth 62.52%
- Total Assets 39.55%
About Gewalife Tech India
Gewalife Tech India Private Limited (GTIPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 November 2018 (Six years and two months 30 days old ). Its registered office is in Chennai, Tamil Nadu, India.
The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mahadev Suresh and Mohanraj Kumaraguru serve as directors at the Company.
Company Details
-
Location
Chennai, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TN2018PTC125723
-
Company No.
125723
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
12 Nov 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Chennai
Industry
Who are the key members and board of directors at Gewalife Tech India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mahadev Suresh
|
Managing Director | 12-Nov-2018 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Mohanraj Kumaraguru
|
Director | 12-Nov-2018 | Current |
Financial Performance of Gewalife Tech India.
Gewalife Tech India Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 3134.17% increase. The company also saw a substantial improvement in profitability, with a 127.21% increase in profit. The company's net worth Soared by an impressive increase of 62.52%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gewalife Tech India?
Unlock access to Gewalife Tech India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Jones Academy Of Clinical Embryology Private LimitedMahadev Suresh is a mutual person
-
Repro Labs India Private Limited
Mahadev Suresh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gewalife Tech India?
Unlock and access historical data on people associated with Gewalife Tech India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gewalife Tech India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gewalife Tech India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.